Global Dry Age-Related Macular Degeneration Market

$2,600.00

产品代码: GH02529R 行业: 地区:

The global dry age-related macular degeneration market is likely to register a CAGR of over 7.1% 随着美元的增量增长 2 预测期内 10 亿 2022-2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global dry age-related macular degeneration market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the dry age-related macular degeneration industry.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the category, stage, 年龄阶层, 给药途径, 最终用户, 和地区. The global market for dry age-related macular degeneration can be segmented by category: diagnosis, treatment. Dry age-related macular degeneration market is further segmented by stage: early AMD, intermediate AMD, late AMD. Based on age group, the dry age-related macular degeneration market is segmented into: 多于 40 年, 多于 60 年, 多于 75 年. On the basis of route of administration, the dry age-related macular degeneration market also can be divided into: injectables, 口服. Dry age-related macular degeneration market by end user is categorized into: 学术研究机构, 诊断中心, 医院 & 诊所, 其他的. The dry age-related macular degeneration market by region can be segmented into: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

By category:
diagnosis
treatment

By stage:
early AMD
intermediate AMD
late AMD

By age group:
– 多于 40 年
– 多于 60 年
– 多于 75 年

按给药途径:
injectables
– 口服

按最终用户:
– 学术研究机构
– 诊断中心
– 医院 & 诊所
– 其他的

按地区:
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (排)

The market research report covers the analysis of key stake holders of the global dry age-related macular degeneration market. Some of the leading players profiled in the report include Alimera Sciences, 公司, 艾尔建公司 (艾伯维公司), Bausch Health Companies Inc., Belite Bio, 公司, Eyestem Research Private Limited, IVERIC bio, 公司, Kubota Pharmaceutical Holdings Co., 有限公司, Ocumension Therapeutics Ltd., Phio Pharmaceuticals Inc., 参天制药公司, 有限公司, Stealth BioTherapeutics Corp., YUYANG DNU Co., 有限公司, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global dry age-related macular degeneration market.
To classify and forecast the global dry age-related macular degeneration market based on category, stage, 年龄阶层, 给药途径, 最终用户, 地区.
To identify drivers and challenges for the global dry age-related macular degeneration market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global dry age-related macular degeneration market.
To identify and analyze the profile of leading players operating in the global dry age-related macular degeneration market.

为什么选择这份报告
Gain a reliable outlook of the global dry age-related macular degeneration market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Dry Age-Related Macular Degeneration Market

对这份报告感兴趣? 立即获取免费样品!
Global Dry Age-Related Macular Degeneration Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

7.1%

页数

90

行业参与者

Alimera Sciences Inc., 艾尔建公司 (艾伯维公司), Bausch Health Companies Inc., Belite Bio Inc, Eyestem Research Private Limited, IVERIC bio Inc., Kubota Pharmaceutical Holdings Co. 有限公司, Ocumension Therapeutics Ltd., Phio Pharmaceuticals Inc., 参天制药. 有限公司, Stealth BioTherapeutics Corp., YUYANG DNU Co. 有限公司.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Dry Age-Related Macular Degeneration Market

请填写我们的表格,我们会尽快回复您.